Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-4,864
Closed -$530K 148
2023
Q4
$530K Buy
4,864
+540
+12% +$56.1K 0.28% 67
2023
Q3
$445K Buy
4,324
+122
+3% +$13.1K 0.24% 73
2023
Q2
$485K Buy
4,202
+815
+24% +$92.5K 0.25% 70
2023
Q1
$360K Buy
+3,387
New +$366K 0.21% 95

Other funds holding MRK

Benedetti & Gucer's MRK Position: Q1 2024 in Review

Benedetti & Gucer sold out of Merck (MRK) in Q1 2024, closing a stake of 4,864 shares — an estimated $530K sold.

Benedetti & Gucer first reported a position in MRK in Q1 2023 and held it in 4 quarters. The position peaked at $530K in Q4 2023. 3,535 funds tracked by Wall St. Rank hold MRK as of Q1 2024.

  • Benedetti & Gucer reported no remaining Merck position as of Q1 2024 after selling out during the quarter.
  • Benedetti & Gucer sold 4,864 Merck shares in Q1 2024, an estimated $530K.
  • Benedetti & Gucer first reported a position in Merck in Q1 2023 and held it in 4 quarters.
  • Benedetti & Gucer's Merck position peaked at $530K in Q4 2023.
  • 3,535 funds tracked by Wall St. Rank held Merck as of Q1 2024.

Based on Benedetti & Gucer's 13F filing for Q1 2024, filed 7 May 2024.